Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Electromed (ELMD) Research & Development (2016 - 2025)

Electromed (ELMD) has disclosed Research & Development for 16 consecutive years, with $384000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Research & Development rose 52.99% to $384000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.2 million, a 58.42% increase, with the full-year FY2025 number at $996000.0, up 51.83% from a year prior.
  • Research & Development was $384000.0 for Q4 2025 at Electromed, up from $241000.0 in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $407000.0 in Q1 2021 to a low of $107000.0 in Q4 2023.
  • A 5-year average of $264150.0 and a median of $287500.0 in 2022 define the central range for Research & Development.
  • Peak YoY movement for Research & Development: crashed 53.19% in 2022, then surged 134.58% in 2024.
  • Electromed's Research & Development stood at $329000.0 in 2021, then plummeted by 53.19% to $154000.0 in 2022, then plummeted by 30.52% to $107000.0 in 2023, then skyrocketed by 134.58% to $251000.0 in 2024, then surged by 52.99% to $384000.0 in 2025.
  • Per Business Quant, the three most recent readings for ELMD's Research & Development are $384000.0 (Q4 2025), $241000.0 (Q3 2025), and $302000.0 (Q2 2025).